P191 Paget trial: topical 5% imiquimod for vulvar paget disease, first results of clinical efficacy
Magnus Lindén(Hallands sjukhus Halmstad), Joanne A. de Hullu(Radboud University Nijmegen), E.B.L. van Dorst(Radboud University Nijmegen), Marc van Beurden(Oncode Institute), Colette van Hees(Erasmus MC), Maaike H.M. Oonk(University Medical Center Groningen), K.A.P. Meeuwis(Radboud University Nijmegen), Mariëtte I.E. van Poelgeest(Leiden University), Johan Bulten(Radboud University Nijmegen), Joanna IntHout(Radboud University Nijmegen), Dorry Boll(Radboud University Nijmegen), Tjalling Bosse(Leiden University Medical Center)
Cited by 2
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
|International Journal of Gynecological Cancer|2015|757
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
|Cancer Treatment Reviews|2016|616
Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health‐related quality of life in breast cancer patients and survivors—a meta‐analysis
|Psycho-Oncology|2010|450
Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
|The Journal of Pathology|2019|401